The Global Chemotherapy
Devices Market, by Product (Catheter, Cannula, Pump, and Others), by End
User (Hospitals, Clinics, and Home Care), and by Region (North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 10.9
billion in 2017, and is projected to exhibit a CAGR of 7.7% over the forecast
period (2018 - 2026).
Technological advancements in
cancer treatments such as chemotherapy and rising investment in cancer care are
reducing the number of cancer deaths worldwide. According to the Cancer Journal
for Clinicians 2016 study, the number of cancer survivors continues to grow in
the U.S. due to increasing number of new cancer diagnoses resulting from a
growing and aging population. As per the same report, over 15.5 million
Americans with a history of cancer were alive on January 1, 2016 and this
number is projected to reach 20.3 million by January 1, 2026. Chemotherapy is
most often administrated via a vein (intravenously) using devices such as catheter
and ports. Long-term central venous access devices are essential for the
management of cancer patients, as they minimize the discomfort of frequent
venipuncture and cannulation. A catheter reduce the number of times to insert a
needle in patient vein. According to the WHO 2017 report, in most upper and
middle income countries, the chemotherapy dosage for some treatments and for
patients with metastatic diseases is done using implantable central venous
catheters or peripherally inserted central catheters (PICC).
* The sample copy includes: Report Summary, Table of Contents,
Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2231
Manufacturers in the chemotherapy
devices market are focused on technological advancements in devices. For
instance, in May 2018, Advanced Chemotherapy Technologies announced development
of an implant, about the size of a large coin for direct delivery of chemo
agents into the pancreas. In 2017, RenovoRx received FDA approval for
RenovoCath dual-balloon infusion catheter to include the delivery of
chemotherapeutics. Browse 24 Market Data Tables and 25 Figures spread through
170 Pages and in-depth TOC on "Chemotherapy Devices Market, by Product
(Catheter, Cannula, Pump, and Others), by End User (Hospitals, Clinics, and
Home Care), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) - Global Forecast to 2026"
Browse Research Report: https://www.coherentmarketinsights.com/market-insight/chemotherapy-devices-market-2231
Key Takeaways of the Chemotherapy
Devices Market:
The global chemotherapy devices
market is expected to expand at a CAGR of 7.7% during the forecast period
(2018–2026), owing to rising cancer incidence coupled with increasing
consumption of tobacco and alcohol, and rising geriatric population base
Among product, the pumps segment
is expected to generate significant revenue in 2018, due to high price as
compared to other products.
Major players operating in the
global chemotherapy devices market include Advanced Chemotherapy Technologies,
Baxter International, Becton, Dickinson Company, B. Braun, Fresenius Kabi,
Halyard Health, ICU Medical, Moog Inc., Micrel Medical, Smiths Group, Terumo
Corporation, and Zyno Medical
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2231
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging market
trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment